Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester

Request For Quotation

Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester manufacturers
Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester Basic information
Product Name:Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester
Synonyms:Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester;Cap-dependent endonuclease-IN-21
CAS:2741952-35-0
MF:C26H23F2N3O7
MW:527.48
EINECS:
Product Categories:
Mol File:2741952-35-0.mol
Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester Structure
Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester Chemical Properties
Boiling point 651.7±65.0 °C(Predicted)
density 1.50±0.1 g/cm3(Predicted)
pka-1.60±0.60(Predicted)
Safety Information
MSDS Information
Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester Usage And Synthesis
UsesCap-dependent endonuclease-IN-21 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-21 inhibits the replication of influenza virus. ap-dependent endonuclease-IN-21 has the potential for the research of influenza virus infection (influenza A) (extracted from patent WO2021233302A1, compound 8B or 8A)[1].
References[1] Shuhui Chen, et al. Fused ring derivatives and their pharmaceutical applications. Patent WO2021233302A1.
Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester Preparation Products And Raw materials
Tag:Carbonic acid, [[(6aS,14R)-11,12-difluoro-3,5,6,6a,7,8-hexahydro-6-methyl-3,5-dioxo-14-phenyl-14H-pyrido[1',2':1,6][1,2,4]triazino[3,2-d][1,5]benzoxazocin-4-yl]oxy]methyl methyl ester(2741952-35-0) Related Product Information
HA/HEMAGGLUTININ protein, INFLUENZA B (ACN29380, SF9) HA/Hemagglutinin Protein, H12N1 (ABB88099, sf9, His) Trypsin Baicalein HA/HEMAGGLUTININ protein, H1N1 (ACR08536,SF9, HIS) HA/hemagglutinin protein, H1N1 (biotinylated, ACP41953.1, HEK293, his)